阿托伐他汀与普罗布考联合治疗对脑梗死颈动脉粥样硬化斑块影响的影像学评价

来源 :中国临床神经科学 | 被引量 : 0次 | 上传用户:lbj120225
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:应用彩色超声、磁共振成像(MRI)技术评价阿托伐他汀与普罗布考联合治疗对脑梗死患者颈动脉粥样硬化(AS)斑块的影响。方法:急性脑梗死存在AS斑块患者120例,随机分为阿托伐他汀(20 mg·d-1)组和阿托伐他汀(20mg·d-1)+普罗布考(500 mg·d-1)组。分别于治疗前、治疗后12和24个月给予彩色多普勒超声、MRI检测颈动脉AS斑块并进行分组分析。结果:阿托伐他汀组治疗后12和24个月时稳定性斑块积分较治疗前增高(P<0.05),不稳定性斑块积分进一步减少(P<0.01);阿托伐他汀+普罗布考组不稳定性斑块积分随着时间进行性降低,各时间点间比较,均差异有统计学意义(P<0.05),且治疗后24个月时不稳定性斑块积分较阿托伐他汀组明显降低。两组治疗后12个月时Ⅱ、Ⅲ级斑块数明显减少,且阿托伐他汀+普罗布考组Ⅲ级斑块数减少更显著;治疗后24个月阿托伐他汀+普罗布考组的Ⅰ级斑块较阿托伐他汀组明显增多,Ⅲ级斑块明显减少。结论:影像学检查显示阿托伐他汀与普罗布考联合治疗具有更强的抗动脉粥样硬化作用,且随着治疗时间的延长表现出更大的优势。 Objective: To evaluate the effect of combination of atorvastatin and probucol on carotid atherosclerosis (AS) plaque in patients with cerebral infarction by color sonography and magnetic resonance imaging (MRI). Methods: A total of 120 AS patients with acute cerebral infarction were randomly divided into atorvastatin (20 mg · d-1) group and atorvastatin (20 mg · d-1) plus probucol 500 mg · d -Group 1. Color Doppler echocardiography was performed before treatment, 12 and 24 months after treatment, and carotid AS plaques were detected by MRI and analyzed by grouping. Results: At 12 and 24 months after treatment, the stability of plaque score in atorvastatin group was higher than that before treatment (P <0.05), and the unstable plaque score was further decreased (P <0.01). Atorvastatin + The score of unstable plaque in the test group decreased progressively with time, and the difference was statistically significant at all time points (P <0.05). At 24 months after treatment, the unstable plaque score was lower than that of Atova The statin group was significantly lower. At 12 months after treatment, the numbers of plaques Ⅱ and Ⅲ decreased significantly, and the numbers of plaques Ⅲ in atorvastatin and probucol decreased more significantly. Atorvastatin + probucol at 24 months after treatment Group Ⅰ plaque than atorvastatin group was significantly increased, Ⅲ plaque was significantly reduced. Conclusions: Imaging studies showed that atorvastatin combined with probucol had a stronger anti-atherosclerotic effect and showed greater advantage with prolonged treatment.
其他文献
目的 比较高压氧(hyperbaric oxygen,HBO)治疗与常规疗法治疗急性脑梗死(acute cerebral infarction,ACI)的疗效及探讨HBO治疗的最佳治疗时间窗.方法 将2006年6月至2010年12
目的:设立优质护理示范岗和警示岗后调查患者满意度并分析.方法:通过每月对伤病员进行问卷调查、现场征求意见、第三方调查(即出院随访)后,对各护理单元患者满意率进行评比,
目的 比较替米沙坦与咪达普利对高血压患者血压变异性的影响.方法 选择80例原发性高血压患者随机分为两组(替米沙坦组和咪达普利组),每组各40例,分别服用替米沙坦40 mg/d、咪
目的:探讨护理干预对胸腔注射顺铂治疗恶性胸腔积液患者的影响.方法:将60例胸腔注射顺铂治疗恶性胸腔积液患者随机分为实验组和对照组各30例,实验组给予精心的护理干预,对照
痛风是一种急性炎症性关节炎,可以完全破坏关节的完整性甚至引起重度残疾.另外,痛风能够加速动脉粥样硬化,最后导致患心血管疾病的风险增加.虽然,痛风与高血压、脑卒中以及慢
目的 观察42例侧脑室引流治疗隐球菌脑膜炎恶性颅高压的效果.方法 对42例确诊为隐球菌脑膜炎合并严重颅高压( >350 mmH2O)的患者采用侧脑室微创引流手术治疗,比较手术前后患者
1例8岁男性患儿因上呼吸道感染静脉滴注清开灵注射液(剂量不详)。输注约1 h,患儿出现面色潮红、双眼睑红肿、眼痛、流泪、畏光、睁眼困难,全身皮肤见大片红色斑疹伴瘙痒,但未
肝干细胞按其来源可划分为肝源性干细胞和非肝源性干细胞,而非肝源性肝干细胞主要指骨髓间充质干细胞、脂肪间充质干细胞、脐带间充质干细胞和脐血间充质干细胞等,脐血间充质
目的 研究搭载兔骨髓基质干细胞(BMSCs)的温敏型壳聚糖/β-甘油磷酸钠(C/GP)水凝胶复合支架对兔桡骨骨折的治疗疗效.方法 将体外培养、扩增的兔BMSCs与C/GP水凝胶混合植入兔
目的 探讨UVA-1及UVA照射对局限性硬皮病患者成纤维细胞中Ⅰ型胶原和基质金属蛋白酶1(MMP-1)表达的影响.方法 局限性硬皮病患者(6例)和健康人(4例)皮肤活检标本进行成纤维细